17.06.2013 Views

EAU 2013 - Programme Book - YouMed

EAU 2013 - Programme Book - YouMed

EAU 2013 - Programme Book - YouMed

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Sunday, 17 March - <strong>EAU</strong> <strong>Programme</strong><br />

Thematic Session 4<br />

11.00 - 12.00 Non-muscle invasive bladder cancer<br />

Silver Hall - Level N2<br />

Chair: J.W.F. Catto, Sheffield (GB)<br />

11.00 - 11.15 State-of-the-art lecture Molecular sub-classification of bladder cancer<br />

M. Sanchez-Carbayo, Madrid (ES)<br />

Aims and objectives<br />

As early events in bladder carcinogenesis, methylation and other epigenetic alterations would provide<br />

diagnostic power complementing previously described genetic factors. As related to different steps in<br />

tumor progression, they could also provide clinical utility for tumour sub-classification. Our group has<br />

been working over the past years on characterising whether hypermethylation of profiles, focused panels<br />

of tumor suppressor genes and individual candidates could classify bladder cancer subgroups according not<br />

only to pathologic or clinical criteria but also to patient outcome. Part of our studies is aiming to evaluate<br />

the clinical utility of CpG hypermethylation for the molecular classification of bladder tumours based on<br />

their aggressiveness and clinical behaviour: from comprehensive CpG array methylation profiling, to several<br />

multiplexed panels of TSGs, and finally characterising specific individual methylated candidates. In this<br />

talk, the major results of these three strategies for bladder cancer sub-classification will be summarised:<br />

using CpG arrays, methylation specific multiplex ligation-dependent probe amplification (MS-MLPA), and<br />

methylation specific polymerase chain reactions (MS-PCR) analyses.<br />

11.15 - 11.30 State-of-the-art lecture Photodynamic diagnosis: Fact or fiction?<br />

M. Burger, Würzburg (DE)<br />

Aims and objectives<br />

The aims of this presentation is a comprehensive depiction of currently available data on the use of<br />

photodynamic diagnosis in bladder cancer and a critical debate and evaluation of the evidence. The<br />

first objective is the depiction of the potential impact of any method improving cystoscopic detection of<br />

bladder cancer. The second objective is the description, the mode of action and debate of the feasibility<br />

of photodynamic diagnosis. The third objective is an overview of currently available data on potential<br />

improvements of detection and recurrence rates compared to standard white light cystoscopy. The fourth<br />

objective is the debate of potential overall benefit for patients. The fifth objective is to pinpoint questions<br />

unanswered to date and the sixth objective is the critical evaluation of what we know so far and a debate on<br />

potential benefits and uncertainties.<br />

11.30 - 11.45 State-of-the-art lecture New advances in perioperative instillation therapy in NMIBC<br />

J.A. Witjes, Nijmegen (NL)<br />

Aims and objectives<br />

The initial resection of bladder tumors is a very important diagnostic and therapeutic tool. Therefore, optimal<br />

initial treatment, including pre-, per-, or postoperative intravesical instillations or other means of help, is an<br />

absolute must in bladder cancer treatment<br />

<strong>EAU</strong> Milan <strong>2013</strong><br />

165<br />

Sunday

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!